These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18816709)

  • 1. Is there a role for defensins in IBD?
    Wehkamp J; Stange EF
    Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S85-7. PubMed ID: 18816709
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of defensins in the pathogenesis of chronic-inflammatory bowel disease].
    Schmid M; Fellermann K; Wehkamp J; Herrlinger K; Stange EF
    Z Gastroenterol; 2004 Apr; 42(4):333-8. PubMed ID: 15095125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotics in inflammatory bowel disease: is it all gut flora modulation?
    Ghosh S; van Heel D; Playford RJ
    Gut; 2004 May; 53(5):620-2. PubMed ID: 15082574
    [No Abstract]   [Full Text] [Related]  

  • 4. Probiotics in IBD.
    Kennedy RJ; Kirk SJ; Gardiner KR
    Gut; 2001 Dec; 49(6):873. PubMed ID: 11758502
    [No Abstract]   [Full Text] [Related]  

  • 5. Defensins and inflammation: the role of defensins in inflammatory bowel disease.
    Ramasundara M; Leach ST; Lemberg DA; Day AS
    J Gastroenterol Hepatol; 2009 Feb; 24(2):202-8. PubMed ID: 19215333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbes, intestinal inflammation and probiotics.
    Khan MW; Kale AA; Bere P; Vajjala S; Gounaris E; Pakanati KC
    Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):81-94. PubMed ID: 22149584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of enteric microflora in inflammatory bowel disease: human and animal studies with probiotics and prebiotics.
    Rioux KP; Madsen KL; Fedorak RN
    Gastroenterol Clin North Am; 2005 Sep; 34(3):465-82, ix. PubMed ID: 16084308
    [No Abstract]   [Full Text] [Related]  

  • 8. Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease.
    Wang ZK; Yang YS; Chen Y; Yuan J; Sun G; Peng LH
    World J Gastroenterol; 2014 Oct; 20(40):14805-20. PubMed ID: 25356041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response.
    Thompson-Chagoyán OC; Maldonado J; Gil A
    Clin Nutr; 2005 Jun; 24(3):339-52. PubMed ID: 15896420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Host-flora interactions in inflammatory bowel disease.
    Shanahan F
    Inflamm Bowel Dis; 2004 Feb; 10 Suppl 1():S16-24. PubMed ID: 15168825
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of probiotics on intestinal barrier function.
    Mennigen R; Bruewer M
    Ann N Y Acad Sci; 2009 May; 1165():183-9. PubMed ID: 19538305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics and inflammatory bowel diseases.
    Bai AP; Ouyang Q
    Postgrad Med J; 2006 Jun; 82(968):376-82. PubMed ID: 16754706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding why probiotic therapies can be effective in treating IBD.
    Fedorak RN
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S111-5. PubMed ID: 18806699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of intestinal homeostasis and immunity with probiotic lactobacilli.
    van Baarlen P; Wells JM; Kleerebezem M
    Trends Immunol; 2013 May; 34(5):208-15. PubMed ID: 23485516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Existing knowledge of the human gut microbiota.
    Macfarlane G
    J Pediatr Gastroenterol Nutr; 2008 Apr; 46 Suppl 1():E10. PubMed ID: 18354313
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of interleukin-22 in inflammatory bowel disease.
    Li LJ; Gong C; Zhao MH; Feng BS
    World J Gastroenterol; 2014 Dec; 20(48):18177-88. PubMed ID: 25561785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Probiotics for inflammatory bowel disease].
    Iizuka H; Takaishi H; Hibi T
    Nihon Rinsho; 2005 May; 63(5):776-80. PubMed ID: 15881169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunology. Therapeutic manipulation of gut flora.
    Shanahan F
    Science; 2000 Aug; 289(5483):1311-2. PubMed ID: 10979858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases.
    Owaga E; Hsieh RH; Mugendi B; Masuku S; Shih CK; Chang JS
    Int J Mol Sci; 2015 Sep; 16(9):20841-58. PubMed ID: 26340622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
    Babickova J; Gardlik R
    World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.